An independent panel of experts advising the U.S. Food and Drug Administration this evening (Wednesday) unanimously voted in favor of vaccinating Moderna's corona disease in infants and children ages six months to five.
The decision paves the way for a sweeping vaccination of all ages in the population, except for infants under six months of age, who are not vaccinated in general.
The experts' assessment is based on data presented by the company, which tested its vaccine on more than 5,000 young children, as well as an independent analysis of the data from food and drug scientists.
The move defines injections to begin entering the arms of young children and infants across the country as early as next week, pending approval from the FDA and a final recommendation from the Centers for Disease Control and Prevention, expected this coming weekend
The decision, if finally approved by the Center for the Prevention and Distribution of Infectious Diseases, will allow the infants and children to be vaccinated as early as next week.
The decision is expected to be made over the weekend.
In addition, the committee should decide whether to recommend Pfizer vaccination for infants and children in the same age group.
"Every pediatrician I know at our hospital has been waiting impatiently for this vote because they can not wait to start giving this vaccine," said panel member Dr. J. Portnoy of Children's Hospital R in Kansas City, Missouri during the committee meeting.
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us